N. Weiss et al., EFFECT OF SHOCK-WAVES AND CISPLATIN ON CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT RODENT TUMORS IN-VIVO, International journal of cancer, 58(5), 1994, pp. 693-699
The effect of a combination of shock waves with cisplatin was examined
in vivo with subcutaneously implanted amelanotic melanomas (A-Mel 3)
in Syrian golden hamsters and cispratin-sensitive or cisplatin-resista
nt fibrosarcoma (SSK2/0 and SSK2/ R2) in C3H mice. In all 3 tumor mode
ls, 4 treatment modalities were compared: control, cisplatin treatment
, shock waves and the combination of shock waves and cisplatin. Shock
waves significantly delayed tumor growth in all 3 tumor models when co
mpared to the respective control group. Cisplatin alone delayed the gr
owth of A-Mel 3 and SSK2/0, whereas SSK2/R2 remained uninfluenced by t
he drug. In all 3 tumor models the combined treatment with shock waves
and cisplatin additively and significantly delayed tumor growth. In A
-Mel-3-bearing animals the combined treatment significantly increased
survival time. The growth of SSK2/0 and SSK2/R2 tumors was delayed to
a similar extent by the combined treatment modality as compared to sho
ck-wave treatment alone, This indicates that the cisplatin resistance
of SSK2/R2 tumors has been overcome by the simultaneous shock wave tre
atment. An increased intracellular cisplatin accumulation in the tumor
s due to shock wave exposure is suggested as the mechanism of interact
ion between shock waves and cisplatin. (C) 1994 Wiley-Liss, Inc.